abstract |
The invention is in the field of the treatment of non-small cell lung cancer. The invention provides agents for the treatment of patients having non-small cell lung cancer and methods of diagnostics related, including methods of predicting response to platinum-based chemotherapy, for patients having, or suspected of having, non-small cell lung cancer. |